Drug recall D-0103-2026
Product
Prazosin Hydrochloride, Capsules, USP, 5 mg, 20 capsules (5x4) cartons, Rx only, Distributed by American Health Packaging, Columbus, Ohio 43217, carton NDC 60687-572-32, Individual unit dose: NDC 60687-572-33
Reason for recall
Failed Impurities/Degradation Specification: presence of N-nitroso Prazosin impurity C above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit
Lots and codes
Lot #: 1016996, 1018336, 1021220, Exp. Date 11/30/2025; 1022421, 1025017, Exp. Date 08/31/2026.
Recall details
- Recalling firm
- Amerisource Health Services LLC, Columbus, OH
- Quantity
- 3,410 cartons
- Distribution
- Nationwide within the United States
- Type
- Voluntary: Firm initiated
- Recall initiated
- October 16, 2025
Related products
- Prazosin Hydrochloride – drug information
- NDC 60687-572 Prazosin Hydrochloride · Prazosin Hydrochloride 5 mg/1 · American Health Packaging